Ischemia clinical trials

Explore recruiting ischemia clinical trials.

Recruiting ischemia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ischemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Improving outcome in subarachnoid hemorrhage with nadroparin

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS <6) based on MRI criteria (DWIFLAIR mismatch)

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Latvia, Italy, Estonia, Czechia, Finland, Netherlands +16 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ORal antibiotics In Acute Mesenteric Ischemia: a multicenter randomized

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A comparison of the effect of autologous bone marrow-derived mononuclear cell therapy with standard treatment on ischemia parameters in diabetic patients with chronic limb-threatening ischemia

Czechia

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab in high-risk patients with Atrial fibrillation who have been deemed unsuitable for oral antiCoagulation (LILAC)

Germany, Czechia, Romania, Bulgaria, Hungary, Poland +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Ischemia trials by city

Ischemia in Toronto Ischemia in Vancouver Ischemia in Montreal Ischemia in Calgary Ischemia in Edmonton Ischemia in Ottawa Ischemia in Winnipeg Ischemia in Quebec City Ischemia in Hamilton Ischemia in Kitchener Ischemia in London Ischemia in Halifax Ischemia in New York Ischemia in Los Angeles Ischemia in Chicago Ischemia in Houston

Ischemia clinical trials

Recruiting ischemia studies right now

Performance of Coronary CT Angiography to Rule Out Coronary Artery Disease After Out-of-hospital Cardiac Arrest

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

The Bridging Antiplatelet Therapy With Cangrelor 2 Study

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Diagnostic Accuracy of ECG-less Gated Cardiac CT in Resuscitated Cardiac Arrest Survivors Without ST Elevation Myocardial Infarction

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

Exploration of the Efficacy and Mechanism of Galantamine (an Extract From Lycoris Aurea) in Treating Ischemic Stroke

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

Atrial Fibrillation Screening Post Ischemic Cerebrovascular Events

The Recovery in Stroke Using PAP Study

A Multicenter Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polyphenol-rich Salicornia Extract in the Progression of Cognitive Decline in a Cohort of Patients With Lacunar Infarcts (SALACUNAR)

The REACTplusNMES Trial: A Double-blinded RCT

Also recruiting in Europe

Improving outcome in subarachnoid hemorrhage with nadroparin

Treatment of acute ischemic stroke due to occlusion of a large vessel by mechanical thrombectomy in patients with unknown onset or not meeting the criteria for CT eligibility (ASPECTS <6) based on MRI criteria (DWIFLAIR mismatch)

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

ORal antibiotics In Acute Mesenteric Ischemia: a multicenter randomized

A comparison of the effect of autologous bone marrow-derived mononuclear cell therapy with standard treatment on ischemia parameters in diabetic patients with chronic limb-threatening ischemia

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab in high-risk patients with Atrial fibrillation who have been deemed unsuitable for oral antiCoagulation (LILAC)

Ischemia trials by city

Other conditions